Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gastrointestinal lymphomas].

W Fischbach1

  • 1Medizinische Klinik II, Klinikum Aschaffenburg, Akademisches Lehrkrankenhaus der Julius-Maximilians-Universität Würzburg. wolfgang.fischbach@klinikum-aschaffenburg.de

Zeitschrift Fur Gastroenterologie
|September 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

German guidelines for the diagnosis and treatment of squamous-cell carcinoma and adenocarcinoma of the esophagus-version 4.0.

ESMO gastrointestinal oncology·2026
Same author

Zeitschrift fur Gastroenterologie·2022
Same author

Zeitschrift fur Gastroenterologie·2021
Same author

[Drug-induced gastrointestinal bleeding].

Der Internist·2019
Same author

[Treatment with platelet aggregation inhibitors and additive proton pump inhibitors?]

Der Internist·2018
Same author

[S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease].

Zeitschrift fur Gastroenterologie·2016
Same journal

[Version 7.0 of the S3 Guideline on Ulcerative Colitis sets out clearly defined treatment goals, an open treatment sequence, and a call for improved cross-sectoral care].

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
Same journal

[Updated S3 guideline on ulcerative colitis].

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
See all related articles

Recent advances in gastrointestinal lymphoma diagnostics and therapy are highlighted, emphasizing the clinical importance of differentiating low- and high-grade lymphomas for tailored treatment strategies.

Area of Science:

  • Gastroenterology
  • Oncology
  • Pathology

Background:

  • Gastrointestinal lymphomas have seen significant diagnostic and therapeutic advancements driven by new insights into their etiology, pathogenesis, and molecular characteristics.
  • The World Health Organization (WHO) classification provides an internationally accepted framework for gastrointestinal lymphomas.
  • Clinical differentiation between low- and high-grade lymphomas is crucial for determining therapeutic strategies, despite not being explicitly detailed in the WHO classification.

Purpose of the Study:

  • To summarize recent progress in the diagnosis and therapy of gastrointestinal lymphomas.
  • To underscore the clinical utility of distinguishing between low- and high-grade lymphomas.
  • To outline the diagnostic and therapeutic approaches for gastrointestinal lymphomas.

Related Experiment Videos

Main Methods:

  • Review of current literature and established classifications (WHO) for gastrointestinal lymphomas.
  • Emphasis on thorough endoscopic-bioptic techniques, including gastric mapping.
  • Inclusion of clinical staging, particularly endoscopic ultrasound, as a necessary diagnostic step.

Main Results:

  • Helicobacter pylori is identified as the primary cause of gastric Mucosa-Associated Lymphoid Tissue (MALT) lymphomas.
  • Untreated sprue is a recognized risk factor for intestinal T-cell lymphomas.
  • Therapeutic options range from Helicobacter pylori eradication to conventional oncological treatments (chemotherapy, radiation, surgery) and a watch-and-wait approach.

Conclusions:

  • Accurate diagnosis, including precise grading and staging of gastrointestinal lymphomas, is essential for effective treatment.
  • Etiological factors like Helicobacter pylori and sprue play critical roles in specific lymphoma types.
  • A personalized therapeutic strategy, encompassing eradication, oncological modalities, or watchful waiting, should be employed based on lymphoma characteristics and patient status.